COR · News · 20260805N

Competition and Market Share

Cencora, Inc. · 2026-08-05 · Importance 10 · Surprise 6

Cencora, McKesson and Cardinal Health together account for more than 90% of the U.S. drug distribution market, indicating a highly concentrated competitive structure. Cencora is one of three leading domestic wholesalers and holds approximately one-third of U.S. drug distribution. The company’s specialty-business momentum is helping it defend its position against pricing and broader industry pressures.

Key facts

• Morningstar said Cencora is one of three leading domestic wholesalers, accounting for about a third of the US drug distribution market. source
• GuruFocus reported Cencora stock rose 3.6% to $317.22 in one trading session and assessed it as 8.1% overvalued at $293.51 with a GF Score of 73/100. source
• Zacks noted year-to-date Cencora shares have declined by 9.3% while the S&P 500 has gained 13%. source